Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

A parasite molecule can speed up skin healing and reduce scarring.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Melanocytes can regenerate around hair follicles in bullous pemphigoid, especially in patients with darker skin.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

A woman with lupus had blood cell destruction, treated successfully with medication.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Dimethyl-fumarate may cause temporary hair loss.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Korean psoriasis patients still use alternative medicine despite effective biologics.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.